Imunon, Inc.

IMNNReported to SECin USCIK 0000749647Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 35. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 35
Form 4 lines at Imunon, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Tardugno Michael HExecutive Chairman of BoardAward$10,1087,169 sharesSep 28, 2026Tardugno Michael HExecutive Chairman of Board$10,108Award · Sep 28Award7,169Sep 28, 2026
Lindborg StacyPresident and CEOAward$9,4436,697 sharesSep 28, 2026Lindborg StacyPresident and CEO$9,443Award · Sep 28Award6,697Sep 28, 2026
Faller Douglas VincentChief Medical OfficerAward$6,1904,390 sharesSep 28, 2026Faller Douglas VincentChief Medical Officer$6,190Award · Sep 28Award4,390Sep 28, 2026
Tardugno Michael HExecutive Chairman of BoardAward$8,5615,824 sharesSep 15, 2026Tardugno Michael HExecutive Chairman of Board$8,561Award · Sep 15Award5,824Sep 15, 2026
Lindborg StacyPresident and CEOAward$8,0915,504 sharesSep 15, 2026Lindborg StacyPresident and CEO$8,091Award · Sep 15Award5,504Sep 15, 2026